P. Heizmann

1.6k total citations
52 papers, 1.3k citations indexed

About

P. Heizmann is a scholar working on Pharmacology, Analytical Chemistry and Spectroscopy. According to data from OpenAlex, P. Heizmann has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 13 papers in Analytical Chemistry and 8 papers in Spectroscopy. Recurrent topics in P. Heizmann's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Analytical Methods in Pharmaceuticals (11 papers) and Analytical Chemistry and Chromatography (8 papers). P. Heizmann is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Analytical Methods in Pharmaceuticals (11 papers) and Analytical Chemistry and Chromatography (8 papers). P. Heizmann collaborates with scholars based in Switzerland, Germany and United States. P. Heizmann's co-authors include W H Ziegler, M Eckert, K. Ballschmiter, C Crevoisier, Karin Jorga, Rodolfo Gasser, E. Weidekamm, B. Ludwig, B. Mikkelsen and Vagn Bach and has published in prestigious journals such as The Lancet, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

P. Heizmann

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Heizmann Switzerland 20 304 283 245 232 178 52 1.3k
E. J. Triggs Australia 26 290 1.0× 405 1.4× 328 1.3× 198 0.9× 159 0.9× 86 2.0k
David N. Bailey United States 26 201 0.7× 304 1.1× 179 0.7× 113 0.5× 63 0.4× 148 1.9k
Roselyne Boulieu France 24 176 0.6× 360 1.3× 295 1.2× 121 0.5× 90 0.5× 107 2.2k
David Lalka United States 23 341 1.1× 364 1.3× 149 0.6× 250 1.1× 227 1.3× 71 1.8k
M.T. Rosseel Belgium 22 167 0.5× 376 1.3× 119 0.5× 312 1.3× 105 0.6× 69 1.3k
Robert A. Upton United States 27 425 1.4× 675 2.4× 291 1.2× 275 1.2× 220 1.2× 62 2.2k
Frans M. Belpaire Belgium 19 211 0.7× 312 1.1× 95 0.4× 79 0.3× 139 0.8× 52 1.3k
Helle R. Angelo Denmark 19 288 0.9× 230 0.8× 269 1.1× 139 0.6× 79 0.4× 79 1.4k
L Paalzow Sweden 24 185 0.6× 223 0.8× 314 1.3× 103 0.4× 181 1.0× 66 1.6k
Kenneth S. Albert United States 26 332 1.1× 561 2.0× 94 0.4× 189 0.8× 131 0.7× 64 1.7k

Countries citing papers authored by P. Heizmann

Since Specialization
Citations

This map shows the geographic impact of P. Heizmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Heizmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Heizmann more than expected).

Fields of papers citing papers by P. Heizmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Heizmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Heizmann. The network helps show where P. Heizmann may publish in the future.

Co-authorship network of co-authors of P. Heizmann

This figure shows the co-authorship network connecting the top 25 collaborators of P. Heizmann. A scholar is included among the top collaborators of P. Heizmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Heizmann. P. Heizmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gromann, T., et al.. (2007). Abstracts. Zeitschrift für Herz- Thorax- und Gefäßchirurgie. 21(3). 93–137.
2.
3.
Jorga, Karin, et al.. (1999). Metabolism and excretion of tolcapone, a novel inhibitor of catechol‐O‐methyltransferase. British Journal of Clinical Pharmacology. 48(4). 513–520. 66 indexed citations
4.
Jorga, Karin, et al.. (1998). Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites*. Clinical Pharmacology & Therapeutics. 63(6). 646–654. 24 indexed citations
5.
Jorga, Karin, et al.. (1998). Pharmacokinetics and pharmacodynamics after oral and intravenous administration of tolcapone, a novel adjunct to Parkinson's disease therapy. European Journal of Clinical Pharmacology. 54(5). 443–447. 27 indexed citations
6.
Gerven, Joop van, G. Roncari, Rik C. Schoemaker, et al.. (1997). Integrated pharmacokinetics and pharmacodynamics of Ro 48–8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. British Journal of Clinical Pharmacology. 44(5). 487–493. 22 indexed citations
7.
Chen, Chao, Goutam C. Mistry, Bradford K. Jensen, et al.. (1996). Pharmacokinetics of Retinoids in Women after Meal Consumption or Vitamin A Supplementation. The Journal of Clinical Pharmacology. 36(9). 799–808. 14 indexed citations
8.
Lohuis, J.A.C.M., T. van Werven, A. Brand, et al.. (1991). Phmacodynamics and pharmacokinetics of carprofen, a non‐steroidal anti‐inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin‐induced mastitis. Journal of Veterinary Pharmacology and Therapeutics. 14(3). 219–229. 57 indexed citations
9.
Heizmann, P., et al.. (1990). Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 527(1). 91–101. 28 indexed citations
10.
Heizmann, P., et al.. (1990). Determination of ornidazole and its main metabolites in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 534. 233–240. 17 indexed citations
11.
Crevoisier, C, et al.. (1989). Plasma tenoxicam concentrations after single and multiple oral doses. European Journal of Drug Metabolism and Pharmacokinetics. 14(1). 23–27. 15 indexed citations
12.
Crevoisier, C, et al.. (1989). Influence of liver cirrhosis upon the pharmacokinetics of tenoxicam.. PubMed. 9(5). 327–34. 4 indexed citations
13.
Nilsen, Odd G., et al.. (1988). Single and multiple dose pharmacokinetics of tenoxicam in the elderly. European Journal of Clinical Pharmacology. 35(5). 563–566. 11 indexed citations
14.
Hinderling, Peter H., D Hartmann, C Crevoisier, Ulrike Moser, & P. Heizmann. (1988). Integrated Plasma and Synovial Fluid Pharmacokinetics of Tenoxicam in Patients with Rheumatoid Arthritis and Osteoarthritis. Therapeutic Drug Monitoring. 10(3). 250–260. 11 indexed citations
15.
Schwartz, D. E., E. Weidekamm, I Mimica, P. Heizmann, & Renée Portmann. (1987). Multiple-Dose Pharmacokinetics of the Antimalarial Drug Fansimef® (Pyrimethamine + Sulfadoxine + Mefloquine) in Healthy Subjects. Chemotherapy. 33(1). 1–8. 18 indexed citations
16.
Heizmann, P., et al.. (1987). Determination of climazolam in the plasma of farm animals by gas chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 415(1). 170–176. 5 indexed citations
17.
Hinderling, Peter H., et al.. (1986). Comparative pharmacokinetics and cardiovascular effects of tiapamil in healthy volunteers and patients with hepatic cirrhosis. European Journal of Clinical Pharmacology. 31(4). 397–404. 3 indexed citations
18.
Sukri, Nono, et al.. (1985). RII AND RIII TYPE RESISTANCE OF PLASMODIUM FALCIPARUM TO COMBINATION OF MEFLOQUINE AND SULFADOXINE/PYRIMETHAMINE IN INDONESIA. The Lancet. 326(8463). 1039–1040. 26 indexed citations
19.
Crevoisier, C, et al.. (1984). Relation entre l'effet clinique et la concentration plasmatique du midazolam chez des sujets volontaires. Annales Françaises d Anesthésie et de Réanimation. 3(3). 162–167. 7 indexed citations
20.
Heizmann, P., M Eckert, & W H Ziegler. (1983). Pharmacokinetics and bioavailability of midazolam in man.. British Journal of Clinical Pharmacology. 16(S1). 43S–49S. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. J. Triggs Breakdown of academic impact, for papers by David N. Bailey Breakdown of academic impact, for papers by Roselyne Boulieu Breakdown of academic impact, for papers by David Lalka Breakdown of academic impact, for papers by M.T. Rosseel Breakdown of academic impact, for papers by Robert A. Upton Breakdown of academic impact, for papers by Frans M. Belpaire Breakdown of academic impact, for papers by Helle R. Angelo Breakdown of academic impact, for papers by L Paalzow Breakdown of academic impact, for papers by Kenneth S. Albert
Rankless by CCL
2026